{"entity":{"type":"insider","cik":"0001743122","url":"/insider/0001743122","json_url":"/insider/0001743122.json","name":"Prout Samantha","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2020-06-17","last":"2024-01-09","span_basis":"filed_date"},"name_variants":[{"name":"Prout Samantha","source":"filing","n_filings":10,"first_seen":"2020-06-17","last_seen":"2024-01-09"}],"transactions":[{"id":3252444,"accession":"0000950170-24-003440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-003440","line_url":"/filing/0000950170-24-003440#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1337.0,"shares_display":"1,337","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":18718.0,"total_display":"18,718.00","total_whole":"18,718","shares_owned_after":80953.0,"shares_owned_after_display":"80,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-09","scope":"insider"},{"id":3252442,"accession":"0000950170-24-003440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-003440","line_url":"/filing/0000950170-24-003440#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30767.0,"shares_display":"30,767","price_per_share":14.0029,"price_display":"14.00","price_state":"stated","total_value":430827.2243,"total_display":"430,827.22","total_whole":"430,827","shares_owned_after":82290.0,"shares_owned_after_display":"82,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8311007,"accession":"0000950170-23-073629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-073629","line_url":"/filing/0000950170-23-073629#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7659.0,"shares_display":"7,659","price_per_share":14.0003,"price_display":"14.00","price_state":"stated","total_value":107228.2977,"total_display":"107,228.30","total_whole":"107,228","shares_owned_after":121912.0,"shares_owned_after_display":"121,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8630021,"accession":"0001209191-23-045479","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-045479","line_url":"/filing/0001209191-23-045479#line-5","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36909.0,"shares_display":"36,909","price_per_share":14.0056,"price_display":"14.01","price_state":"stated","total_value":516932.6904,"total_display":"516,932.69","total_whole":"516,933","shares_owned_after":137003.0,"shares_owned_after_display":"137,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-11","scope":"insider"},{"id":4793022,"accession":"0001209191-21-055206","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-055206","line_url":"/filing/0001209191-21-055206#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4925.0,"shares_display":"4,925","price_per_share":12.0139,"price_display":"12.01","price_state":"stated","total_value":59168.4575,"total_display":"59,168.46","total_whole":"59,168","shares_owned_after":83170.0,"shares_owned_after_display":"83,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-03","filed_date":"2021-09-08","scope":"insider"},{"id":5381572,"accession":"0001209191-21-053351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-053351","line_url":"/filing/0001209191-21-053351#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5045.0,"shares_display":"5,045","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":55495.0,"total_display":"55,495.00","total_whole":"55,495","shares_owned_after":83170.0,"shares_owned_after_display":"83,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider"},{"id":3208352,"accession":"0001209191-20-057338","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-057338","line_url":"/filing/0001209191-20-057338#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5931.0,"shares_display":"5,931","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":118620.0,"total_display":"118,620.00","total_whole":"118,620","shares_owned_after":17135.0,"shares_owned_after_display":"17,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":2545856,"accession":"0001209191-20-045776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-045776","line_url":"/filing/0001209191-20-045776#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":15.05,"price_display":"15.05","price_state":"stated","total_value":2979.9,"total_display":"2,979.90","total_whole":"2,980","shares_owned_after":17135.0,"shares_owned_after_display":"17,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2801939,"accession":"0001104659-20-081474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-081474","line_url":"/filing/0001104659-20-081474#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":15.8,"price_display":"15.80","price_state":"stated","total_value":3128.4,"total_display":"3,128.40","total_whole":"3,128","shares_owned_after":17135.0,"shares_owned_after_display":"17,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-02","filed_date":"2020-07-06","scope":"insider"},{"id":3258111,"accession":"0001209191-20-038630","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038630","line_url":"/filing/0001209191-20-038630#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3366.0,"shares_display":"3,366","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":50490.0,"total_display":"50,490.00","total_whole":"50,490","shares_owned_after":17135.0,"shares_owned_after_display":"17,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":3089855,"accession":"0001209191-20-037464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-037464","line_url":"/filing/0001209191-20-037464#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001743122","owner_name":"Prout Samantha","owner_display_name":"Prout Samantha","owner_url":"/insider/0001743122","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2932.0,"shares_display":"2,932","price_per_share":12.9463,"price_display":"12.95","price_state":"stated","total_value":37958.5516,"total_display":"37,958.55","total_whole":"37,959","shares_owned_after":17135.0,"shares_owned_after_display":"17,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Officer (Chief Accounting Officer)","n_filings":10,"first_seen":"2020-06-17","last_seen":"2024-01-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001743122","retrieved_at":"2026-08-25T06:17:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}